NAD + in aging, metabolism, and neurodegeneration
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Nicotinamide adenine dinucleotide (NAD + ) is a coenzyme found in all living cells. It serves both as a critical coenzyme for enzymes that fuel reduction-oxidation reactions, carrying electrons from one reaction to another, and as a cosubstrate for other enzymes such as the sirtuins and poly(adenosine diphosphate–ribose) polymerases. Cellular NAD + concentrations change during aging, and modulation of NAD + usage or production can prolong both health span and life span. Here we review factors that regulate NAD + and discuss how supplementation with NAD + precursors may represent a new therapeutic opportunity for aging and its associated disorders, particularly neurodegenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, the total NAD+ + NADH pool was smaller in the apoE4 cells, suggesting that apoE4 impairs NAD+ synthetic capacity [68].”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [68]
In the citing paper
“Nicotinamide phosphoribosyl transferase (NAMPT) catalyzes the rate limiting step in the NAD salvage pathway from nicotinamide (NAM) (Garten et al., 2015; Verdin, 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Verdin, 2015
In the citing paper
“Persistently activated PARP1, however, consumes large amounts of NAD+, an essential coenzyme of sirtuins (SIRTs) (69).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [69]
In the citing paper
“restoration of NAD levels with the NAD precursor vitamins nicotinamide riboside (NR), nicotinamide (NAM) and nicotinic acid (NA), in addition to the biosynthetic NAD precursor nicotinamide mononucleotide (NMN), appears to mitigate several age-associated diseases2-4.”
From Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages (2020) · cites this paper as [4]
In the citing paper
“The NAD+ salvage pathway starts from the recycling of nicotinamide (NAM) to nicotinamide mononucleotide (NMN) by intracellular nicotinamide phosphoribosyltransferase (iNAMPT), followed by the conversion of NMN into NAD+ via the NMNATs (Bogan and Brenner, 2008; Verdin, 2015).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Verdin, 2015
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats
Braidy, N., Guillemin, G. J., Mansour, H., Chan-Ling, T., Poljak, A., & Grant, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019194 · Cited by 594
RetractedLópez-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Cited by
Items 201–300 of 1,000
Korotchkina, L. G., Kazyulkin, D. N., Komarov, P. G., Polinsky, A., Andrianova, E. L., Joshi, S. P., Gupta, M., Vujcic, S., Kononov, E., Toshkov, I. A., et al. (2020) · Leukemia · doi:10.1038/s41375-019-0692-5 · Cited by 82
NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
Guo, X., Tan, S., Wang, T., Sun, R., Li, S., Tian, P., Li, M., Wang, Y., Zhang, Y., Yan, Y., et al. (2022) · Hepatology · doi:10.1002/hep.32658 · Cited by 91
“[12,13] Simultaneously, mammalian cells synthesize NAD+ through three pathways: the de novo pathway from tryptophan; the Preiss‐Handler (PH) pathway from dietary nicotinic acid (NA) and NA mononucleotide (NaMN); and the salvage pathway from nicotinamide (NAM) or nicotinamide riboside.[14,15] However, during aging and…”
BackgroundVisfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases
Dakroub, A. H., Nasser, S. A., Kobeissy, F. H., Yassine, H. M., Orekhov, A. N., Sharifi‐Rad, J., Iratni, R., EL‐Yazbi, A. F., & Eid, A. H. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30345 · Cited by 87
“Whereas the former plays a regulatory role in NAD biosynthesis, the latter is associated with many hormone‐like signaling pathways and intracellular signaling cascades (Revollo et al., 2007; Verdin, 2015).”
BackgroundVreones, M. P., Mustapić, M., Moaddel, R., Pucha, K. A., Lovett, J., Seals, D. R., Kapogiannis, D., & Martens, C. R. (2022) · Aging Cell · doi:10.1111/acel.13754 · Cited by 83
“Overall, augmenting brain- based NAD+ metabolism has emerged as a promising strategy for the treatment of neurological disorders (Brakedal et al., 2022; Verdin, 2015).”
Antiaging effects of bioactive molecules isolated from plants and fungi
Martel, J., Ojcius, D. M., Ko, Y., Chang, C., & Young, J. D. (2019) · Medicinal Research Reviews · doi:10.1002/med.21559 · Cited by 81
“Oral intake of hydroxycitrate in mice for 2 days induces autophagy throughout the body.189 This compound is thus likely to produce antiaging effects by mimicking CR. DNA damage, which increases with aging, leads to activation of poly(ADP‐ribose) polymerase, marking DNA for repair and consuming NAD+.157 HFD‐induced inf…”
BackgroundInfluentialFabrication of MOF-based Nanozyme sensor arrays and their application in disease diagnosis
Wang, M., Zhang, H., Yan, S., Zhou, Y., Guo, X., An, D., Zhong, W., & Zhang, Y. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216506 · Cited by 80
Viña, J., Tarazona‐Santabalbina, F. J., Pérez‐Ros, P., Martínez‐Arnau, F. M., Borrás, C., González, G. O., Salvador‐Pascual, A., & Gómez‐Cabrera, M. C. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.04.005 · Cited by 87
“Searching for specific activators of sirtuins is a challenge for the scientists to increase longevity (Verdin, 2015).”
Interaction between epigenetic and metabolism in aging stem cells
Brunet, A., & Rando, T. A. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.12.009 · Cited by 76
“It was recently shown that decreases in levels of cellular NAD(+), a co-substrate for Sirtuin deacetylases and other enzymes [33], lead to elevated H4K16 acetylation and the induction of expression of a myogenic program in MuSCs during activation out of quiescence [34 ].”
BackgroundGSK3β Regulates Brain Energy Metabolism
Martin, S. A., Souder, D. C., Miller, K. N., Clark, J. P., Sagar, M. A. K., Eliceiri, K. W., Puglielli, L., Beasley, T. M., & Anderson, R. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.045 · Cited by 85
“The role of metabolism in age-related disease has become a major focus in aging research, and NAD specifically, due to its central role in intermediate metabolism and as a regulator of sirtuin activity, has moved to the fore in this arena (Chini et al., 2017; Verdin, 2015; Yoshino et al., 2017).”
BackgroundThe Aging Metabolome—Biomarkers to Hub Metabolites
Sharma, R., & Ramanathan, A. (2020) · PROTEOMICS · doi:10.1002/pmic.201800407 · Cited by 76
Carnosine and the processes of ageing
Hipkiss, A. R., Baye, E., & de Courten, B. V. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.06.002 · Cited by 78
Nutrition, metabolism, and epigenetics: pathways of circadian reprogramming
Sato, T., & Sassone‐Corsi, P. (2022) · EMBO Reports · doi:10.15252/embr.202152412 · Cited by 81
“NAD ⁺ can be synthesized de novo from diverse dietary sources (e.g., tryptophan) or regenerated from NAM via the salvage pathway (Canto et al , 2015; Verdin, 2015).”
Cytochrome b5 reductases: Redox regulators of cell homeostasis
Hall, R., Yuan, S. S., Wood, K. C., Katona, M., & Straub, A. C. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102654 · Cited by 83
Pervizaj-Oruqaj, L., Ferrero, M. R., Matt, U., & Herold, S. (2024) · European Respiratory Review · doi:10.1183/16000617.0263-2023 · Cited by 82
“Regarding immunometabolism in the ageing macrophage phenotype, NAD + (nicotinamide adenine dinucleotide) has substantial age-related fluctuations [159].”
BackgroundNicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration
Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7145 · Cited by 78
Dissecting Murine Muscle Stem Cell Aging through Regeneration Using Integrative Genomic Analysis
Shcherbina, A., Larouche, J., Fraczek, P., Yang, B. A., Brown, L. A., Markworth, J. F., Chung, C. H., Khaliq, M., de Silva, K., Choi, J. J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107964 · Cited by 76
“The coupled loss of OxPhos and gain of SAMs from the 1CC observed in aging has previously been shown to reduce NAD-dependent histone deacetylases (HDACs), such as sirtuins (Verdin, 2015), and increase chromatin accessibility (Ducker and Rabinowitz, 2017).”
BackgroundZhou, Q., Zhu, L., Qiu, W., Liu, Y., Yang, F., Chen, W., & Xu, R. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.38487 · Cited by 80
“The decrease of NAD+ indicates the dysfunction of basic physiological system of whole body [6].”
BackgroundNeuroprotection in glaucoma: recent advances and clinical translation
Guymer, C., Wood, J. P. M., Chidlow, G., & Casson, R. J. (2018) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13336 · Cited by 80
“Wallerian degeneration slow mice (Wld) contains a spontaneous dominant mutation that protects against neuronal insults, such as Parkinson’s disease, hypoxic–ischaemic injury, toxic neuropathy (taxol) and others.(145,147) Williams et al.”
BackgroundMapping of γ/δ T cells Reveals Vδ2 T cells Resistance to Senescence
Xu, W., Monaco, G., Wong, E., Tan, W. L. W., Kared, H., Simoni, Y., Tan, S. W., How, W., Tan, C. T. Y., Lee, B. T. K., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.053 · Cited by 82
Aberrant NAD+ metabolism underlies Zika virus–induced microcephaly
Pang, H., Jiang, Y., Li, J., Wang, Y., Nie, M., Xiao, N., Wang, S., Song, Z., Ji, F., Chang, Y., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00437-0 · Cited by 83
The Promise of Niacin in Neurology
Wuerch, E. C., Urgoiti, G. B. R., & Yong, V. W. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01376-2 · Cited by 80
Procyanidins and Alzheimer’s Disease
Zhao, S., Zhang, L., Yang, C., Li, Z., & Rong, S. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1469-6 · Cited by 80
Frailty index as a biomarker of lifespan and healthspan: Focus on pharmacological interventions
Palliyaguru, D. L., Moats, J. M., Di Germanio, C., Bernier, M., & de Cabo, R. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.03.005 · Cited by 71
“NAD primarily acts as a co-enzyme in redox reactions and functions as a mediator in glucose and lipid metabolism and mitochondrial function, interacting especially with sirtuins, poly(ADP-ribose) polymerases (PARPs), and the cyclic ADP-ribose synthases (CD38, CD157) [38] [39].”
BackgroundNicotinamide adenine dinucleotide as a photocatalyst
Kim, J., Lee, S. H., Tieves, F., Paul, C. E., Hollmann, F., & Park, C. B. (2019) · Science Advances · doi:10.1126/sciadv.aax0501 · Cited by 74
Hu, Q., Wu, D., Walker, M. A., Wang, P., Tian, R., & Wang, W. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100116 · Cited by 82
“mitochondria, cytosol, and nucleus, where it regulates important and distinct functions, from energymetabolism, gene expression, and DNA repair to protein modification (Goodman et al., 2020; Katsyuba and Auwerx, 2017; Verdin, 2015; Xiao and Loscalzo, 2020; Zhao et al., 2018).”
Systemic Photoprotection in Melanoma and Non-Melanoma Skin Cancer
Hyeraci, M., Papanikolaou, E. S., Grimaldi, M., Ricci, F., Pallotta, S., Monetta, R., Minafò, Y. A., Lella, G. D., Galdo, G., ABENI, D. D., et al. (2023) · Biomolecules · doi:10.3390/biom13071067 · Cited by 85
“NAD mediates electron transfer by oscillating between its oxidized (NAD+) and reduced (NADH) states [37].”
BackgroundNMNAT: It’s an NAD+ synthase… It’s a chaperone… It’s a neuroprotector
Brazill, J. M., Li, C. V., Zhu, Y., & Zhai, R. G. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.03.014 · Cited by 76
“NAD is a vital coenzyme important for metabolism and redox biology, as well as a substrate in multiple signaling processes [27].”
Identification of the nicotinamide salvage pathway as a new toxification route for antimetabolites
Buonvicino, D., Mazzola, F., Zamporlini, F., Resta, F., Ranieri, G., Camaioni, E., Muzzi, M., Zecchi, R., Pieraccini, G., Dölle, C., et al. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.01.012 · Cited by 73
New tools for redox biology: From imaging to manipulation
Bilan, D. S., & Belousov, V. V. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.004 · Cited by 74
“19 signaling, biosynthesis, cell death and survival, embryonic development and aging, and pathogenesis [146, 149-155].”
BackgroundJha, M. K., Lee, Y., Russell, K. A., Yang, F., Dastgheyb, R. M., Deme, P., Ament, X. H., Chen, W., Liu, Y., Guan, Y., et al. (2020) · Glia · doi:10.1002/glia.23710 · Cited by 73
“Second, upregulation of c-Jun and demyelinating neuropathy was also recently reported following dysregulation of NAD biosynthesis, a key cellular factor in glycolytic metabolism (Verdin, 2015).”
BackgroundFang, F., Zhuang, P., Feng, X., Liu, P., Liu, D., Huang, H., Li, L., Chen, W., Liu, L., Sun, Y., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.035 · Cited by 77
Gut microbiome signatures of extreme environment adaption in Tibetan pig
Zhao, F., Yang, L., Zhang, T., Zhuang, D., Wu, Q., Yu, J., Tian, C., & Zhang, Z. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00395-3 · Cited by 76
Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action
Mohajer, N., Du, C. Y., Checkcinco, C., & Blumberg, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.780888 · Cited by 72
SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration
Sasaki, Y., Kakita, H., Kubota, S., Sène, A., Lee, T. J., Ban, N., Dong, Z., Lin, J. B., Boye, S. L., DiAntonio, A., et al. (2020) · eLife · doi:10.7554/elife.62027 · Cited by 78
CD38 Mediates Lung Fibrosis by Promoting Alveolar Epithelial Cell Aging
Cui, H., Xie, N., Banerjee, S., Dey, T., Liu, R.-M., Antony, V. B., Sanders, Y. Y., Adams, T. S., Gómez, J. L., Thannickal, V. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2151oc · Cited by 76
Pham, T. X., Bae, M., Kim, M.-B., Lee, Y., Hu, S., Kang, H., Park, Y.-K., & Lee, J.-Y. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.009 · Cited by 73
β-nicotinamide mononucleotide (NMN) production in Escherichia coli
Marinescu, G. C., Popescu, R. G., Stoian, G., & Dinischiotu, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-30792-0 · Cited by 74
Managò, A., Audrito, V., Mazzola, F., Sorci, L., Gaudino, F., Gizzi, K., Vitale, N., Incarnato, D., Minazzato, G., Ianniello, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12055-2 · Cited by 73
Mitophagy in depression: Pathophysiology and treatment targets
Tripathi, A., Scaini, G., Barichello, T., Quevedo, J., & Pillai, A. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.08.016 · Cited by 75
Mutations in NDUFS1 Cause Metabolic Reprogramming and Disruption of the Electron Transfer
Ni, Y., Hagras, M. A., Konstantopoulou, V., Mayr, J. A., Stuchebrukhov, A. A., & Meierhofer, D. (2019) · Cells · doi:10.3390/cells8101149 · Cited by 74
“We further want to mention that an imbalance of the NADH/NAD+ ratio in itself may affect all aspects of impaired metabolism [85,86].”
BackgroundNicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing
Navarro, M. N., Heras, M. M. G. D. L., & Mittelbrunn, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15477 · Cited by 82
“The cADPR synthases CD38 and CD157 produce the calcium-releasing second messenger cyclic ADP-ribose (cADPR) (Kar et al., 2020; Lee & Zhao, 2019), and they act as major NAD + consumers.”
BackgroundMethodInfluentialAdvances in NAD-Lowering Agents for Cancer Treatment
Ghanem, M. S., Monacelli, F., & Nencioni, A. (2021) · Nutrients · doi:10.3390/nu13051665 · Cited by 75
“Overall, mammalian cells utilize the following three biosynthetic pathways to generate NAD: the de novo pathway, the Preiss–Handler (PH) pathway, and the salvage pathway (Figure 1) [8,9].”
BackgroundInfluentialMolecular mechanism of azoxy bond formation for azoxymycins biosynthesis
Guo, Y., Li, Z. H., Xia, T.-Y., Du, Y., Mao, X., & Li, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-12250-1 · Cited by 69
Stoyas, C. A., Bushart, D. D., Switonski, P. M., Ward, J. M., Alaghatta, A., Tang, M., Niu, C., Wadhwa, M., Huang, H., Savchenko, A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.11.019 · Cited by 74
“To explain the dramatic decrease in Sirt1 enzymatic function in SCA7, we considered a role for PARP1, as PARP1 can consume large amounts of NAD+, the necessary co-factor for Sirt1 (Verdin, 2015).”
BackgroundHong, Y., Liu, M., Wang, L., Zu, Y., Wu, C., Li, C., Zhang, R., Lu, H., Li, F., Xi, S., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00651-9 · Cited by 72
Translational geroscience: A new paradigm for 21st century medicine
Kaeberlein, M. R. (2017) · Translational Medicine of Aging · doi:10.1016/j.tma.2017.09.004 · Cited by 86
“With the development of potential geroprotective compounds such as rapamycin and other mTOR inhibitors (34, 35), metformin (36), NAD+ precursors (37), and senolytics (38), there has been growing optimism that clinical approaches to directly target aging may soon be a reality.”
BackgroundRedox Biology in Neurological Function, Dysfunction, and Aging
Franco, R., & Vargas, M. R. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7509 · Cited by 68
“Importantly, changes in the balance between NAD+ consumption/depletion and synthesis/recycling are thought to alter cellular bioenergetics, metabolism, and redox homeostasis (9).”
BackgroundIdentification of evolutionary and kinetic drivers of NAD-dependent signaling
Bockwoldt, M., Houry, D., Niere, M., Gossmann, T. I., Reinartz, I., Schug, A. H., Ziegler, M., & Heiland, I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902346116 · Cited by 70
Tezel, G. (2021) · Cells · doi:10.3390/cells10061372 · Cited by 78
“The NAD, a redox cofactor that participates in many biochemical reactions critical for mitochondrial function, cellular metabolism, aging, and neurodegeneration [97,98], has recently been linked to glaucomatous neurodegeneration [79].”
BackgroundMoulin, M., & Ferreiro, A. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.003 · Cited by 70
“form, is implicated in redox reactions, hauling electrons from one reaction to another [34].”
BackgroundMetabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
Kľučková, K., & Tennant, D. A. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2801-6 · Cited by 70
“Since then, the acquisition of pseudohypoxic phenotypes has been observed in a number of pathological and physiological processes, including inflammation (Halligan et al. 2016), differentiation (Mohlin et al. 2017) and aging (Verdin 2015).”
BackgroundKynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
Biernacki, T., Sandi, D., Bencsik, K., & Vécsei, L. (2020) · Cells · doi:10.3390/cells9061564 · Cited by 70
Re‐equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction
Sun, C., Wang, K., Stock, A. J., Gong, Y., Demarest, T. G., Yang, B., Giri, N., Harrington, L., Alter, B. P., Savage, S. A., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103420 · Cited by 62
“To determine whether low NAD levels were responsible for the reduced PARylation and SIRT1-deacetylation activities in DC fibroblasts, we cultured DC fibroblasts with the NAD precursor, NR. NR is converted to NMN by NRK1/2 synthesizing enzymes, followed by conversion of NMN to NAD by NMNATs.”
InfluentialLiu, Q., Zhuang, Y., Song, X., Niu, Q., Sun, Q., Li, X., Li, N., Liu, B., Huang, F., & Qiu, Z. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00535-x · Cited by 68
Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease
Kim, N., & Lee, H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147697 · Cited by 73
Xiao, Q., Xiong, Z., Yu, C., Zhou, J., Shen, Q., Wang, L., Xie, X., & Fu, Z. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112699 · Cited by 70
Brain NAD Is Associated With ATP Energy Production and Membrane Phospholipid Turnover in Humans
Cuenoud, B. M., İpek, Ö., Shevlyakova, M., Beaumont, M., Cunnane, S. C., Gruetter, R., & Xin, L. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.609517 · Cited by 67
“Based on extensive in-vitro and animal data, one would predict that aging and many neurological diseases would lead to a decrease in brain total NAD (tNAD, NADH+NAD+) levels, NAD+/NADH redox ratio, or both (Verdin, 2015; Lautrup et al., 2019; Katsyuba et al., 2020; McReynolds et al., 2020).”
BackgroundNADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
Bian, C., Zhang, C., Luo, T., Vyas, A., Chen, S.-H., Liu, C., Kassab, M. A., Yang, Y., Kong, M., & Yu, X. (2019) · Nature Communications · doi:10.1038/s41467-019-08530-5 · Cited by 71
Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases
Lee, W. S., Ham, W., & Kim, J. (2021) · Life · doi:10.3390/life11121301 · Cited by 70
The Metabolic Landscape in Osteoarthritis
Wu, X., Fan, X., Crawford, R., Xiao, Y., & Prasadam, I. (2022) · Aging and Disease · doi:10.14336/ad.2021.1228 · Cited by 69
“There is currently little known about CD38 or CD157 in chondrocytes during the process of OA.”
BackgroundInfluentialDrug-Induced Mitochondrial Toxicity in the Geriatric Population: Challenges and Future Directions
Will, Y., Shields, J. E., & Wallace, K. B. (2019) · Biology · doi:10.3390/biology8020032 · Cited by 67
“It may be as simple as the age-associated decrease of [NAD+] [41,42] that is responsible for the lower rates of both mitochondrial biogenesis and mitophagy in aged tissues.”
BackgroundMetabolic Syndrome and the Cellular Phase of Alzheimer's Disease
Pugazhenthi, S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.016 · Cited by 69
Qiao, A., Jin, X., Pang, J., Moskophidis, D., & Mivechi, N. F. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201607091 · Cited by 67
“Considering the strong evidence directly linking NAD+/NADH redox imbalance and ATP insufficiency to diverse human pathologies (Verdin, 2015), a key challenge in deciphering metabolic adaptation is the identification of the regulators that maintain cellular energetic efficiency.”
BackgroundPeriyasamy, S., John, S., Padmavati, R., Rajendren, P., Thirunavukkarasu, P., Gratten, J., Vinkhuyzen, A. A. E., McRae, A. F., Holliday, E. G., Nyholt, D. R., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.1335 · Cited by 69
The balance between NAD+ biosynthesis and consumption in ageing
Strømland, Ø., Diab, J., Ferrario, E., Sverkeli, L. J., & Ziegler, M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111569 · Cited by 67
“Given the importance of NAD availability, it is interesting to note that NAD levels decrease with ageing, and recently, a strong link has emerged between age-related NAD decline and age-related diseases [32, 33].”
Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
Adornetto, A., Rombolà, L., Morrone, L. A., Nucci, C., Corasaniti, M. T., Bagetta, G., & Russo, R. (2020) · Nutrients · doi:10.3390/nu12103158 · Cited by 64
“Retinal levels of NAD decrease with aging [44], and evidence suggest that therapies increasing NAD levels may be effective against glaucoma [45–47].”
BackgroundBerberine-induced TFEB deacetylation by SIRT1 promotes autophagy in peritoneal macrophages
Zheng, Y., Kou, J., Wang, P., Ye, T., Wang, Z., Gao, Z., Cong, L., Li, M., Dong, B., Yang, W. P., et al. (2021) · Aging · doi:10.18632/aging.202566 · Cited by 66
“Moreover, activation of PARPs or cADPR CD38 in immune cells depletes NAD [39, 40].”
BackgroundTowards an Understanding of Energy Impairment in Huntington’s Disease Brain
Dubinsky, J. M. (2017) · Journal of Huntington s Disease · doi:10.3233/jhd-170264 · Cited by 72
Ammonia sensitive SLC4A11 mitochondrial uncoupling reduces glutamine induced oxidative stress
Ogando, D. G., Choi, M., Shyam, R., Li, S., & Bonanno, J. A. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101260 · Cited by 64
Aging alters acetylation status in skeletal and cardiac muscles
Yeo, D., Kang, C., & Ji, L. L. (2020) · GeroScience · doi:10.1007/s11357-020-00171-7 · Cited by 67
“Furthermore, a decrease in cellular NAD availability due to aging has been identified as a main reason for organ’s and tissue’s inability to deal with increased protein acetylation tendency despite high SIRT levels (Imai and Guarente 2014; Johnson and Imai 2018; Verdin 2015).”
BackgroundInfluentialNAD+ in COVID-19 and viral infections
Zheng, M., Schultz, M. B., & Sinclair, D. A. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.02.001 · Cited by 62
“which remove acyl groups and create O-acyl-ADP-ribose; and CD38, BST, and SARM1, which create (cyclic)-ADP-ribose [44].”
InfluentialLamb, D. A., Moore, J. H., Mesquita, P. H. C., Smith, M. A., Vann, C. G., Osburn, S. C., Fox, C. D., Lopez, H. L., Ziegenfuss, T. N., Huggins, K. W., et al. (2020) · Aging · doi:10.18632/aging.103218 · Cited by 62
NAD + Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy
Chiao, Y. A., Chakraborty, A. D., Light, C. M., Tian, R., Sadoshima, J., Shi, X., Gu, H., & Lee, C. F. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008170 · Cited by 69
Aman, Y., Frank, J., Lautrup, S., Matysek, A., Niu, Z., Yang, G., Shi, L., Bergersen, L. H., Storm‐Mathisen, J., Rasmussen, L. J., et al. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111194 · Cited by 67
“An increasing body of evidence over the past decades demonstrates that decline in levels of NAD+ contribute to the ten hallmarks of cellular ageing and age-related diseases (Fivenson et al., 2017; Lautrup et al., 2019a; Nikiforov et al., 2015; Verdin, 2015).”
BackgroundNAD+ Metabolism and Regulation: Lessons From Yeast
Croft, T., Venkatakrishnan, P., & Lin, S.-J. (2020) · Biomolecules · doi:10.3390/biom10020330 · Cited by 64
“Future studies to understand the multiple roles of NAD+ intermediates, as well as novel factors regulating NAD+ homeostasis are also highly anticipated NAD+ metabolism is an emerging therapeutic target for several human diseases [5,7,11,14,183,184].”
BackgroundOsteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging
Wang, H., Yuan, T., Wang, Y., Liu, C., Li, D., Li, Z., & Sun, S. (2024) · Aging Cell · doi:10.1111/acel.14092 · Cited by 69
“For example, reduced activity of complex I lowers NAD + concentration, subsequently repressing the activation of FOXO, manganese superoxide dismutase (MnSOD), and catalase via SIRT (van de Ven et al., 2017; Verdin, 2015).”
BackgroundCiarlo, E., Heinonen, T., Théroude, C., Herderschee, J., Mombelli, M., Lugrin, J., Pfefferlé, M., Tyrrell, B. E., Lensch, S., Acha‐Orbea, H., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01037 · Cited by 64
Audrito, V., Managò, A., Vecchia, S. L., Zamporlini, F., Vitale, N., Baroni, G., Cignetto, S., Serra, S., Bologna, C., Stingi, A., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx198 · Cited by 71
“By acting as a cofactor for enzymes involved in energy metabolism, NAD facilitates electron transfer in central metabolic processes (3).”
BackgroundInfluentialBalancing DNA repair to prevent ageing and cancer
Stead, E. R., & Bjedov, I. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112679 · Cited by 73
The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson’s disease
Chen, Z., Rasheed, M., & Deng, Y. (2021) · Brain Pathology · doi:10.1111/bpa.13012 · Cited by 65
Mitophagy in aging and longevity
Guo, J., & Chiang, W. (2021) · IUBMB Life · doi:10.1002/iub.2585 · Cited by 62
“Previous studies demonstrated that the intracellular NAD level declines during aging and that the reduction of NAD may be related to the development of several age-related disorders including atherosclerosis, arthritis, hypertension, cognitive decline, diabetes, and cancer.(238) Therefore, the restoration of NAD may b…”
BackgroundPoljšak, B., Kovač, V., Špalj, S., & Milisav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032959 · Cited by 62
“The NAMPT functions as the rate-limiting enzyme of the aforementioned pathway [22] generating NMN and pyrophosphate (PP) from NAM and α-D-5-phosphoribosyl-”
BackgroundInfluentialChemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine
Liu, K., Chen, Y., Xie, M., Li, K., & Ding, S. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.007 · Cited by 66
Vignier, N., Chatzifrangkeskou, M., Rodríguez, B. M., Mericskay, M., Mougenot, N., Wahbi, K., Bonne, G., & Muchir, A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy278 · Cited by 67
CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools
Chmielewski, J. P., Bowlby, S. C., Wheeler, F. B., Shi, L., Sui, G., Davis, A. L., Howard, T. D., D'Agostino, R. B., Miller, L. D., Sirintrapun, S. J., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0526 · Cited by 64
“Introduction NADþ metabolism is associated with everything from aging and healthy lifespan, to diabetes, neurocognitive function, and cancer, among others (1, 2).”
BackgroundEmerging strategies, applications and challenges of targeting NAD+ in the clinic
Zhang, J., Wang, H., Lautrup, S., Nilsen, H. L., Treebak, J. T., Watne, L. O., Selbæk, G., Wu, L. E., Omland, T., Pirinen, E., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00947-6 · Cited by 67
“Initially discovered over a century ago, these coenzymes have been the subject of intensive research, resulting in several Nobel Prizes for fundamental discoveries in this field 4 .”
Self-citationPalzer, L., Bader, J. J., Angel, F., Witzel, M., Blaser, S., McNeil, A., Wandersee, M. K., Leu, N. A., Lengner, C. J., Cho, C. E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.091 · Cited by 63
“(2009),Feige et al. (2008), Krishnan et al. (2012), and Verdin (2015).”
Wang, L.-F., Cao, Q. N., Wen, K., Xiao, Y., Chen, T., Guan, X., Liu, Y., Zuo, L., Qian, Y., Deng, K., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01125 · Cited by 61
“Several studies reported that the content of NAD+ was declined during aging and senescence (Mouchiroud et al., 2013; Verdin, 2015; Zhu et al., 2015).”
BackgroundARDD 2020: from aging mechanisms to interventions
Mkrtchyan, G. V., Abdelmohsen, K., Andreux, P., Bagdonaite, I., Barzilai, N., Brunak, S., Cabreiro, F., de Cabo, R., Campisi, J., Cuervo, A. M., et al. (2020) · Aging · doi:10.18632/aging.202454 · Cited by 58
“NAD + -utilizing enzymes for NAD + that may explain its age-dependent decline across multiple tissues [73].”
BackgroundSelf-citationThe Drama of Wallerian Degeneration: The Cast, Crew, and Script
Zhang, K., Jiang, M., & Fang, Y. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071819-103917 · Cited by 64
Aβ promotes CD38 expression in senescent microglia in Alzheimer’s disease
Hu, Y., Huang, Y., Xing, S., Chen, C., Shen, D., & Chen, J. (2022) · Biological Research · doi:10.1186/s40659-022-00379-1 · Cited by 64
Broady, A. J., Loichinger, M. H., Ahn, H. J., Davy, P. M. C., Allsopp, R., & Bryant‐Greenwood, G. D. (2016) · Placenta · doi:10.1016/j.placenta.2016.12.018 · Cited by 61
“Mitochondria have their own NAD+ generating system, driven by SIRT3 [28] and NAD+ salvage pathway, driven by Nampt [36].”
BackgroundCatic, A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.003 · Cited by 63
Mitochondrial translation deficiency impairs NAD+‐mediated lysosomal acidification
Yagi, M., Toshima, T., Amamoto, R., Do, Y., Hirai, H., Setoyama, D., Kang, D., & Uchiumi, T. (2021) · The EMBO Journal · doi:10.15252/embj.2020105268 · Cited by 63
“NAD + levels decrease in many organisms with age, resulting in reduced Sirtuin activity and downstream activation of autophagy (Hsu et al , 2009; Verdin, 2015).”
Meyer, T., Shimon, D., Youssef, S., Yankovitz, G., Tessler, A., Chernobylsky, T., Gaoni-Yogev, A., Perelroizen, R., Budick-Harmelin, N., Steinman, L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211310119 · Cited by 65
“Of note, NAD+ could also be transported to the extracellular space(13, 14).”
BackgroundImpact of NAD+ metabolism on ovarian aging
Liang, J., Huang, F., Song, Z., Tang, R., Zhang, P., & Chen, R. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00398-w · Cited by 63
Does eating less make you live longer and better? An update on calorie restriction
Picca, A., Pesce, V., & Lezza, A. M. S. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s126458 · Cited by 53
“sensors that influence enzymes to rapidly recuperate cell homeostasis.(105,106) When NAD+ accumulates, such as during”
Yuan, L., Zhai, L., Qian, L., Huang, D., Ding, Y., Xiang, H., Liu, X., Thompson, J. W., Liu, J., He, Y., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0043-5 · Cited by 59
Tapias, V., McCoy, J. L., & Greenamyre, J. T. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101164 · Cited by 61
Horimatsu, T., Blomkalns, A. L., Ogbi, M., Moses, M. M., Kim, D. S., Patel, S. Y., Gilreath, N., Reid, L. E., Benson, T. W., Pye, J., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz303 · Cited by 59
Metadata
- Authors
- Verdin, E.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Verdin, Eric
- ORCID
- Verdin, Eric
- Venue
- Science
- Published
- 2015-12-04
- Volume
- 350
- Issue
- 6265
- Pages
- 1208-1213
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2284984697
- Cited by
- 1,319
- References
- 116
- Citations by year
- 2026: 177 · 2025: 149 · 2024: 137 · 2023: 120 · 2022: 129 · 2021: 171 · 2020: 123 · 2019: 112 · 2018: 89 · 2017: 70 · 2016: 40 · 2015: 1
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK085610)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- NAD+, aging, metabolism, neurodegeneration, sirtuins, poly(ADP-ribose) polymerase, NAD+ precursors, NAD+ supplementation, healthspan, lifespan, redox reactions, coenzymes
- MeSH terms
- Aging, Diabetes Mellitus, Type 2, DNA Damage, Fatty Liver, Humans, Mitochondria, NAD, Obesity, Oxidation-Reduction, Poly(ADP-ribose) Polymerases, Neurodegenerative Diseases, Sirtuins, Biosynthetic Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.